FindTrial
Sign In

study of immunupathogenesis of extrafacial melasma in skin of color

A Clinical, Dermoscopic And Immunohistochemical study of extrafacial melasma in skin of color - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/09/057682
Enrollment
30
Registered
2023-09-15
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L814- Other melanin hyperpigmentation

Interventions

Intervention1: Nil: Nil Control Intervention1: nil: nil

Sponsors

Pigmentary Disorders Society
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age over 18 years Clinical diagnosis of extra-facial melasma characterized by the presence of brownish hyperpigmented spots under regular illumination, with irregular borders, symmetrically distributed in body areas except the face.

Exclusion criteria

Exclusion criteria: 1 History of post-inflammatory hyperpigmentation and hyperchromic contact dermatitis with symptoms such as itching, stinging, burning, or local trauma before the appearance of the lesions. 2 Pregnant women 3 Patients with contraindications for skin biopsy such as a history of keloid formation or coagulation disorders 4. Patients not giving consent

Design outcomes

Primary

MeasureTime frame
1.To compare pathogenic mechanisms of facial and extrafacial melasma on immunohistochemical analysisTimepoint: at 1 year—

Secondary

MeasureTime frame
2. To study the immunohistochemistry in extrafacial melasmaTimepoint: 1 year—

Countries

India

Contacts

Public ContactDr Manju Daroach

AIIMS BILASPUR

dr.manju.derma@aiimsbilaspur.edu.in7018056721

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026